Dermatology Research and Practice / 2014 / Article / Tab 3

Clinical Study

Effect of Oral PUVAsol on the Quality of Life in Indian Patients Having Chronic Plaque Psoriasis

Table 3

DLQI scores in study group at baseline and after 12 weeks of regular treatment.

Type of study subjectsPretreatment (baseline)Posttreatment (after 12 weeks) value

Total cases ( = 40)14.45 ± 3.199.40 ± 6.520.0004
Patients having lesions at mixed sites ( = 8)14.27 ± 2.668.33 ± 4.870.0001
Patients with lesions at unexposed sites ( = 32)14.20 ± 5.0111.20 ± 7.730.0587
Patients who achieved ≥75% PASI improvement ( = 8)12.25 ± 3.064.00 ± 2.730.0001
Patients who achieved 50–75% PASI improvement ( = 16)13.38 ± 2.835.75 ± 1.240.0001
Patients with <50% PASI improvement ( = 12)16.5 ± 2.3914.67 ± 4.410.1737
Patients reporting worsening of disease ( = 4)16.00 ± 2.3119.75 ± 2.630.0006